creatine has been researched along with Lupus Nephritis in 6 studies
Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).
Excerpt | Relevance | Reference |
---|---|---|
" MMF was designed to enhance the oral bioavailability of the parent compound." | 2.40 | Mizoribine and mycophenolate mofetil. ( Ishikawa, H, 1999) |
"Active proliferative lupus nephritis of moderate or severe degree was observed in 65 per cent of patients at the initial biopsy." | 1.28 | Study of lupus nephritis in males. ( Hamaguchi, K; Hiki, Y; Kobayashi, Y; Shigematsu, H; Tateno, S; Tsuchida, H, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Liu, C | 1 |
Wang, Z | 1 |
Hu, X | 1 |
Ito, H | 1 |
Takahashi, K | 1 |
Nakajima, M | 1 |
Tanaka, T | 1 |
Zhu, P | 1 |
Li, XK | 1 |
Condon, MB | 1 |
Ashby, D | 1 |
Pepper, RJ | 1 |
Cook, HT | 1 |
Levy, JB | 1 |
Griffith, M | 1 |
Cairns, TD | 1 |
Lightstone, L | 1 |
Yahya, TM | 1 |
Dhanyamraju, S | 1 |
Harrington, TM | 1 |
Prichard, JW | 1 |
Yang, CW | 1 |
Yu, CC | 1 |
Ko, YC | 1 |
Huang, CC | 1 |
Ishikawa, H | 1 |
Tateno, S | 1 |
Hiki, Y | 1 |
Hamaguchi, K | 1 |
Tsuchida, H | 1 |
Shigematsu, H | 1 |
Kobayashi, Y | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis During the Induction of Remission Period-EUROLUPUS vs. RITUXILUP Regimen: A Randomized Study[NCT05207358] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-03-02 | Recruiting | ||
CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid[NCT03492255] | 49 participants (Actual) | Interventional | 2018-04-12 | Terminated (stopped due to Significative difference between percentage of renal response (primary outcome) between the two study arms.) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for creatine and Lupus Nephritis
Article | Year |
---|---|
Mizoribine and mycophenolate mofetil.
Topics: Animals; Arthritis; Carbon-Nitrogen Ligases; Cell Cycle; Cell Division; Clinical Trials as Topic; Cr | 1999 |
1 trial available for creatine and Lupus Nephritis
Article | Year |
---|---|
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Cohort Studies; Creatine; Drug Substitution; Dr | 2013 |
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Cohort Studies; Creatine; Drug Substitution; Dr | 2013 |
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Cohort Studies; Creatine; Drug Substitution; Dr | 2013 |
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Cohort Studies; Creatine; Drug Substitution; Dr | 2013 |
4 other studies available for creatine and Lupus Nephritis
Article | Year |
---|---|
5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
Topics: Aminolevulinic Acid; Animals; B-Lymphocytes; Blood Urea Nitrogen; Body Weight; CD8-Positive T-Lympho | 2021 |
Spontaneous resolution of lupus nephritis following withdrawal of etanercept.
Topics: Autoantibodies; Blood Chemical Analysis; Creatine; Etanercept; Female; Humans; Immunoglobulin G; Kid | 2013 |
Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.
Topics: Animals; Body Weight; Cell Count; Creatine; Crosses, Genetic; Enzyme Inhibitors; Female; Guanidines; | 1998 |
Study of lupus nephritis in males.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Complement C3; Complement C4; Complement Hemolytic Activ | 1991 |